Taken together, these findings provided a comprehensive analysis of the PTPN family members and shed light on the critical role of PTPN2 as a potential therapeutic target and diagnostic biomarker for improving PAAD survival. The gene discussed is PTPN2; the disease is pancreatic adenocarcinoma.